BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2520335)

  • 1. In vivo utilization of intravenously supplied L-alanyl-L-glutamine in various tissues of the rat.
    Stehle P; Ratz I; Fürst P
    Nutrition; 1989; 5(6):411-5. PubMed ID: 2520335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced intracellular glutamine depletion. The potential use of glutamine-containing peptides in parenteral nutrition.
    Fürst P; Albers S; Stehle P
    Beitr Infusionther Klin Ernahr; 1987; 17():117-36. PubMed ID: 3120690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body autoradiography in rats after intravenous administration of L-alanyl-L-[U-14C]glutamine.
    Stehle P; Ratz I; Fürst P
    Ann Nutr Metab; 1991; 35(4):213-20. PubMed ID: 1897901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-alanyl-L-tyrosine as a tyrosine source during total parenteral nutrition. Infusion at 0.5 and 2 mmoles/kg/day in adult rats.
    Daabees TT; Stegink LD
    Pediatr Res; 1979 Aug; 13(8):894-9. PubMed ID: 113768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Administration of glutamine and its dipeptides in parenteral nutrition. Which patients are candidates?].
    Cardona Pera D
    Nutr Hosp; 1998; 13(1):8-20. PubMed ID: 9578682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-alanyl-L-tyrosine as a tyrosine source during intravenous nutrition of the rat.
    Daabees TT; Stegink LD
    J Nutr; 1978 Jul; 108(7):1104-13. PubMed ID: 96233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine-containing dipeptides in parenteral nutrition.
    Fürst P; Albers S; Stehle P
    JPEN J Parenter Enteral Nutr; 1990; 14(4 Suppl):118S-124S. PubMed ID: 2119457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Route of administration (enteral or parenteral) affects the contribution of L-glutamine to de novo L-arginine synthesis in mice: a stable-isotope study.
    Boelens PG; Melis GC; van Leeuwen PA; ten Have GA; Deutz NE
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E683-90. PubMed ID: 16684848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of glutamine supplied intravenously as alanylglutamine.
    Fürst P; Albers S; Stehle P
    Metabolism; 1989 Aug; 38(8 Suppl 1):67-72. PubMed ID: 2668705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of amino acids supplied intravenously in healthy man as synthetic dipeptides: kinetic evaluation of L-alanyl-L-glutamine and glycyl-L-tyrosine.
    Albers S; Wernerman J; Stehle P; Vinnars E; Fürst P
    Clin Sci (Lond); 1988 Nov; 75(5):463-8. PubMed ID: 3254762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination kinetics of L-alanyl-L-glutamine in ICU patients.
    Berg A; Rooyackers O; Norberg A; Wernerman J
    Amino Acids; 2005 Nov; 29(3):221-8. PubMed ID: 16049639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine dipeptides in clinical nutrition.
    Fürst P; Pogan K; Stehle P
    Nutrition; 1997; 13(7-8):731-7. PubMed ID: 9263278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a synthetic dipeptide mixture as the source of amino acids for total parenteral nutrition in a subhuman primate (baboon). Plasma concentration, metabolic clearance, and urinary excretion of a series of dipeptides.
    Steinhardt HJ; Paleos GA; Brandl M; Fekl WL; Adibi SA
    Gastroenterology; 1984 Jun; 86(6):1562-9. PubMed ID: 6425106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of perioperative parenteral glutamine-dipeptide supplementation on plasma endotoxin level, plasma endotoxin inactivation capacity and clinical outcome.
    Yao GX; Xue XB; Jiang ZM; Yang NF; Wilmore DW
    Clin Nutr; 2005 Aug; 24(4):510-5. PubMed ID: 16054522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of L-alanyl-L-glutamine in the immune response in vitro.
    Kircher B; Eibl G; Enrich B; Lätzer K; Herold M; Niederwieser D
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):702-8. PubMed ID: 12602115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological availability of glutamine from N-acetyl-L-glutamine in intravenous administration. Studies in the rat].
    Neuhäuser M; Bässler KH
    Infusionsther Klin Ernahr; 1986 Dec; 13(6):292-6. PubMed ID: 3102374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a nutritional need for glutamine in catabolic patients.
    Fürst P; Albers S; Stehle P
    Kidney Int Suppl; 1989 Nov; 27():S287-92. PubMed ID: 2517677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of L-alanyl-L-tyrosine by nephrectomized rats when infused as part of a total parenteral nutrition regimen.
    Daabees TT; Stegink LD
    J Nutr; 1979 Sep; 109(9):1633-9. PubMed ID: 113513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral nutrition with an amino acid solution containing a mixture of dipeptides. Evidence for efficient utilization of dipeptides in man.
    Brandl M; Sailer D; Langer K; Engelhardt A; Kleinhenz H; Adibi SA; Fekl W
    Beitr Infusionther Klin Ernahr; 1987; 17():103-16. PubMed ID: 3120689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral supplementation with glutamine and alanyl-glutamine on glutamine, glutamate, and glutathione status in trained rats and subjected to long-duration exercise.
    Cruzat VF; Tirapegui J
    Nutrition; 2009 Apr; 25(4):428-35. PubMed ID: 19056244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.